PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsAlzheimer's memory loss due to gene blockade reversed in mice

BioNews

Alzheimer's memory loss due to gene blockade reversed in mice

Published 31 January 2013 posted in News and appears in BioNews 647

Author

Dr Maria Botcharova

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

An enzyme associated with memory loss can be blocked to reverse symptoms of Alzheimer's disease in mice, a study has shown...

An enzyme associated with memory loss can be blocked to reverse symptoms of Alzheimer's disease in mice, a study has shown.

The enzyme, called histone deacetylase 2 (HDAC2), is overproduced in people with the disease. The researchers, based at Massachusetts Institute of Technology (MIT), suggest that a drug to inhibit HDAC2 could be developed to help Alzheimer's patients.

HDAC2 affects genes responsible for learning and forming new memories. HDAC2 doesn't directly inhibit the genes, but instead interferes with gene expression epigenetically. It does this by causing the DNA strand to become more tightly wound, effectively hiding sections of DNA from the proteins that read and activate the genes.

'If your memory is everything that you know written in a book, then in order to have access, you have to open the book and to turn the pages', Dr Johannes Graff, the study's lead author, told US News. In Alzheimer's, 'this mechanism actually closes your memory book and makes the pages - the genes - inaccessible'.

Previous research suggests that a major cause of Alzheimer's disease is the formation of protein fragments called beta-amyloids, into solid plaques. These plaques clog up the space between brain cells and stop them functioning correctly.

This is not contradicted by the new findings. Indeed, the team at MIT suggests that beta-amyloids may actually trigger overproduction of HDAC2. However, reducing plaque formation would not reverse symptoms of Alzheimer's after HDAC2 had begun its work.

Although the current research identifies a new target for drug therapy in Alzheimer's disease, it may take a long time before an HDAC2 inhibitor becomes available. 'Clinical trials for a new drug may take as long as five years to begin', said Dr Li-Huei Tsai, the research group's team leader. 'If everything goes well, to become an approved drug would probably take at least ten years'.

Dr Brad Dickerson, associate professor of neurology at Harvard Medical School, who was not involved in the study told US News that 'the leap from animal studies to human clinical trials is a big one and always takes many years'. However, he mentioned that HDAC2 inhibitors are currently under investigation as cancer drugs. Those trials, he said, 'will provide an indication of their side effects and other important information'.

The Alzheimer's Society states that there are currently 750,000 people with Alzheimer's disease in the UK.

Related Articles

PET BioNews
News
22 May 2020 • 2 minutes read

Enzyme discovered critical to age-related cognitive decline

by Joanne Delange

New research has led to the discovery of an enzyme that can help to reverse the DNA damage associated with ageing and Alzheimer's disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
2 December 2013 • 2 minutes read

Fear can be inherited, mouse study finds

by Siobhan Chan

Mice that were conditioned to fear a specific smell passed down this fear to their offspring, suggesting that traumatic events can affect gene expression...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 September 2013 • 2 minutes read

Forget-me-now: Memory loss gene found in mice

by Rhys Baker

Whether painful memories linger or fade may be down to the expression of a single gene, according to researchers at Massachusetts Institute of Technology (MIT), USA...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 August 2013 • 2 minutes read

Gene activity decline behind 'senior moments'

by Michelle Downes

Age-related memory loss could be the result of low levels of protein in the brain, according to researchers at Columbia University Medical Center (CUMC)...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 March 2013 • 2 minutes read

Protection against dementia may run in families

by Dr Sophie Pryor

Families with higher levels of a protein linked to inflammation may be at a reduced risk of dementia....

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
31 January 2013 • 1 minute read

Alzheimer's brain cells grown from skin cells of Down's syndrome patients

by Dr Caroline Hirst

Skin cells from volunteers with Down's syndrome have been turned into brain cells in order to provide a new model for researchers to study Alzheimer's disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 November 2012 • 3 minutes read

Same genetic mutation linked to ALS and dementia

by George Frodsham

Researchers have identified a strong link between a genetic fault and two common neurological disorders. Two independent studies have found that the mutation is common in patients with amyotrophic lateral sclerosis (ALS) and patients with frontotemporal dementia (FTD), particularly if the disease is familial...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
25 October 2012 • 2 minutes read

New Alzheimer's disease genes discovered

by Alison Cranage

International scientists including researchers at Cardiff University, UK and the University of Pennsylvania, USA have discovered five genetic variations associated with Alzheimer's disease. The findings are published in two papers in the journal Nature Genetics...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
17 October 2012 • 1 minute read

Cells grown in lab could help research into Alzheimer's disease

by Alison Cranage

Scientists at Northwestern University, Chicago have transformed stem cells into a key type of brain cell that dies early in Alzheimer's disease. Their findings will allow scientists to study what causes the cells to die in Alzheimer's, potentially paving the way for new treatments....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Final two women in US 'baby-selling' ring sentenced

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

4 July 2022 • 2 minutes read

Genetic and epigenetic causes of IVF embryo arrest discovered

4 July 2022 • 2 minutes read

Dutch donor-conceived people seek answers

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856